Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 691

1.

The implementation of integrated emotion-oriented care: did it actually change the attitude, skills and time spent of trained caregivers?

van der Kooij CH, Dröes RM, de Lange J, Ettema TP, Cools HJ, van Tilburg W.

Dementia (London). 2013 Sep;12(5):536-50. doi: 10.1177/1471301211435187. Epub 2012 Mar 16.

PMID:
24337328
2.

Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.

Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN.

J Pak Med Assoc. 2012 Jul;62(7):677-80.

3.

Unidimensional 12-item Zarit Caregiver Burden Interview for the assessment of dementia caregivers' burden obtained by item response theory.

Ballesteros J, Santos B, González-Fraile E, Muñoz-Hermoso P, Domínguez-Panchón AI, Martín-Carrasco M.

Value Health. 2012 Dec;15(8):1141-7. doi: 10.1016/j.jval.2012.07.005. Epub 2012 Oct 4.

4.

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Jakobsson J, Zetterberg H, Blennow K, Johan Ekman C, Johansson AG, Landén M.

Neuropsychopharmacology. 2013 Mar;38(4):664-72. doi: 10.1038/npp.2012.231. Epub 2012 Nov 6.

5.

REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial.

Woods RT, Bruce E, Edwards RT, Elvish R, Hoare Z, Hounsome B, Keady J, Moniz-Cook ED, Orgeta V, Orrell M, Rees J, Russell IT.

Health Technol Assess. 2012;16(48):v-xv, 1-116. doi: 10.3310/hta16480.

6.

Effect of rhythmic auditory cueing on gait in people with Alzheimer disease.

Wittwer JE, Webster KE, Hill K.

Arch Phys Med Rehabil. 2013 Apr;94(4):718-24. doi: 10.1016/j.apmr.2012.11.009. Epub 2012 Nov 13.

PMID:
23159787
8.

Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.

Egefjord L, Gejl M, Møller A, Brændgaard H, Gottrup H, Antropova O, Møller N, Poulsen HE, Gjedde A, Brock B, Rungby J.

Dan Med J. 2012 Oct;59(10):A4519.

PMID:
23158895
9.

Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment.

Grill JD, Karlawish J, Elashoff D, Vickrey BG.

Alzheimers Dement. 2013 May;9(3):356-359.e1. doi: 10.1016/j.jalz.2012.03.001. Epub 2012 Nov 8.

10.

Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: a pilot randomized controlled trial.

Suttanon P, Hill KD, Said CM, Williams SB, Byrne KN, LoGiudice D, Lautenschlager NT, Dodd KJ.

Clin Rehabil. 2013 May;27(5):427-38. doi: 10.1177/0269215512460877. Epub 2012 Nov 1.

PMID:
23117349
11.

Communicating with patients who have advanced dementia: training nurse aide students.

Beer LE, Hutchinson SR, Skala-Cordes KK.

Gerontol Geriatr Educ. 2012;33(4):402-20. doi: 10.1080/02701960.2012.702165.

PMID:
23095223
12.

Cognitive behavioural therapy (CBT) for anxiety in people with dementia: study protocol for a randomised controlled trial.

Spector A, Orrell M, Lattimer M, Hoe J, King M, Harwood K, Qazi A, Charlesworth G.

Trials. 2012 Oct 23;13:197. doi: 10.1186/1745-6215-13-197.

13.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study.

Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M.

J Neural Transm (Vienna). 2013 May;120(5):813-9. doi: 10.1007/s00702-012-0902-z. Epub 2012 Oct 18.

PMID:
23076723
14.

Relapse risk after discontinuation of risperidone in Alzheimer's disease.

Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B.

N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058. Erratum in: N Engl J Med. 2012 Dec 20;367(25):2458.

15.

Dementia and risk of adverse warfarin-related events in the nursing home setting.

Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH.

Am J Geriatr Pharmacother. 2012 Oct;10(5):323-30. doi: 10.1016/j.amjopharm.2012.09.003.

PMID:
23063288
16.

Efficacy of nonpharmacologic interventions for agitation in advanced dementia: a randomized, placebo-controlled trial.

Cohen-Mansfield J, Thein K, Marx MS, Dakheel-Ali M, Freedman L.

J Clin Psychiatry. 2012 Sep;73(9):1255-61. doi: 10.4088/JCP.12m07918.

PMID:
23059151
17.

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients.

Han HJ, Kim BC, Lee JY, Ryu SH, Na HR, Yoon SJ, Park HY, Shin JH, Cho SJ, Yi HA, Choi MS, Heo JH, Park KW, Kim KK, Choi SH.

Dement Geriatr Cogn Disord. 2012;34(3-4):167-73. doi: 10.1159/000342927. Epub 2012 Oct 5.

PMID:
23051684
18.

Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan.

Cheng KC, Chen YL, Lai SW, Mou CH, Tsai PY, Sung FC.

BMC Nephrol. 2012 Sep 29;13:129. doi: 10.1186/1471-2369-13-129.

19.

Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.

Schölzel-Dorenbos CJ, Arons AM, Wammes JJ, Rikkert MG, Krabbe PF.

Health Qual Life Outcomes. 2012 Sep 25;10:118. doi: 10.1186/1477-7525-10-118.

20.

The effects of slow-stroke back massage on minutes of nighttime sleep in persons with dementia and sleep disturbances in the nursing home: a pilot study.

Harris M, Richards KC, Grando VT.

J Holist Nurs. 2012 Dec;30(4):255-63. doi: 10.1177/0898010112455948. Epub 2012 Sep 24.

PMID:
23007716

Supplemental Content

Loading ...
Support Center